Missouri Trial Begins Over Allegations Against Abbott Labs’ Similac Formula and Infant Health Risks

The first trial against Abbott Laboratories over its infant formula has commenced in Missouri. During his opening statement, Jake Plattenberger argued that Abbott’s cow’s milk-based formula, marketed under the Similac brand, was responsible for causing necrotizing enterocolitis (NEC) in Robynn Davis, the premature daughter of plaintiff Margo Gill. NEC is a severe gastrointestinal inflammation that primarily affects premature infants. For more information on the trial and ongoing proceedings, visit the original article here.